<DOC>
	<DOCNO>NCT00498940</DOCNO>
	<brief_summary>The purpose study investigate efficacy optimize temporary biventricular pacing ( BiVP ) patient undergo open-heart surgery preoperative LV dysfunction intraventricular conduction delay . This study compare extend temporary biventricular pace versus standard care assess patient randomize two group , conclusion cardiopulmonary bypass , conclusion pharmacologic circulatory support intensive care unit . In addition , effect biventricular pace test patient , three time point , use different measure blood flow . Results research demonstrate whether temporary BiVP improve cardiac output open-heart surgery whether ventricular pace optimization increase cardiac output set . Success would lead development recommendation use BiVP postoperatively would stimulate development pacemaker appropriate feature . Our primary hypothesis optimum pacing protocol ( POPT ) increase cardiac index ( CI ) 15 % ( approximately 2.30 2.64 L/min/m2 ) compare standard care measure thermodilution 12-24 hour postoperatively . Secondary objective include define POPT three time point within 24 hour surgery . We examine form cardiac dysfunction benefit temporary pacing use direct indirect measure perfusion cardiac function . We also analyze survival , length stay , incidence arrhythmia , cost postoperative care .</brief_summary>
	<brief_title>Biventricular Pacing After Cardiopulmonary Bypass</brief_title>
	<detailed_description>Biventricular pacing ( BiVP ) reverse intraventricular conduction delay ( IVCD ) leave ventricular ( LV ) dysfunction dilate cardiomyopathy ( DCM ) . BiVP improve LV function cardiac index ( Cl ) energy cost . In MIRACLE trial , patient DCM , IVCD LV ejection fraction &lt; 35 % , demonstrate improved subjective objective measure exercise tolerance cardiac function BiVP . BiVP benefit many , selection criterion fully develop , 30 % recipient `` nonresponders , '' cost $ 2 billion/year . Preliminary data suggest BiVP benefit patient low output state cardiac surgery . We plan assess surgical application BiVP assess mechanisms action optimization . We randomize 190 cardiac surgery patient LV dysfunction preoperatively pace standard care group . BiVP optimize continue postoperatively patient stable . BiVP assess transiently patient three time point . The primary end point 15 % improvement thermal dilution Cl measure intensive care unit ( ICU ) . Effects heart rate , atrioventricular delay , ventricular pacing site , interventricular delay Cl assess use randomize sequence data collection . Secondary endpoint include incidence arrhythmia , inotropic support , urine output , weight gain , morbidity , mortality , ICU cost . These study important high probability clinical benefit . The method employ provide precision , breadth measurement , range pace site superior setting . The protocol provide new important scientific information benefit surgical patient also general population BiVP recipient .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>LV ejection fraction &lt; 41 % QRS duration &gt; 99 msec Or : Mitral Aortic Valve Repair Replacement Congenital Heart Disease Intracardiac Shunts Preoperative Pacing Heart Block ( 2nd 3rd degree ) Sinus Bradycardia Heart Rate &gt; 120 beat per min Cardiopulmonary Bypass Preoperative Atrial Fibrillation Previous Cardiac Surgery Inability undergo biventricular pacing prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>LV function , Compliance , wall motion , echocardiography</keyword>
</DOC>